Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Baicalin suppresses iron accumulation after substantia nigra injury

  • Factors predicting functional recovery of upper limb after peripheral nerve injuries

  • Collaborative care intervention improves depression among teens

  • Sleep apnea treatment is effective for older people

  • Young children's sipping/tasting of alcohol reflects parental modeling

  • Prenatal alcohol exposure is associated with later excess weight/obesity during adolescence

  • Alcoholics have an abnormal CD8 T cell response to the influenza virus

  • New estrogen-based compound suppresses binge-like eating behavior in female mice

  • Protecting brains of very preterm infants

  • Fear, safety and the role of sleep in human PTDS

  •